Neptune™ T-Cell Separation System
Built to bring life-changing cell therapies closer to patients by reducing manufacturing time and cost.
Neptune™ T-Cell Separation System is Bio-ReCell’s next-generation T-cell separation device, designed to simplify one of the first and most critical steps in cell therapy manufacturing. Using proprietary flow-through separation technology, Neptune™ delivers highly purified T cells without magnetic particles, centrifugation or dedicated proprietary hardware.
Commercial launch is planned for January 2027.
WHY WE BUILT NEPTUNE™
Cell therapies have the potential to transform the treatment of cancer, autoimmune diseases and many other life-threatening conditions. Yet for many patients, these therapies remain inaccessible due to the complexity and cost of manufacturing.
We believe that improving patient access begins by simplifying manufacturing. That’s why we developed the Neptune™ T-Cell Separation System. By eliminating unnecessary processing steps, magnetic particles and proprietary equipment, Neptune™ is designed to reduce manufacturing complexity while preserving the quality of isolated T cells for downstream applications.
NEPTUNE™ T-CELL SEPARATION COLUMN
The Bio-ReCell flow-through column contains antibody-functionalized separation beads, enabling rapid negative selection without the use of magnetic particles or centrifugation.
As the cell suspension flows through the column, unwanted cell populations are selectively retained while untouched target T cells pass through for collection.
To learn more about the technology behind our separation system and the results it achieves, read our latest whitepaper on the Neptune™ T-Cell Separation System.
DOWNLOAD WHITEPAPERKEY FEATURES
Closed-System Separation
Flow-through antibody-based negative selection performed within a closed disposable cartridge.
Under 30-Minute Cycle
Rapid automated processing with minimal hands-on time.
No Magnetic Particles
No magnetic labelling. No centrifugation. No detectable residual particles.
High Cell Quality
High CD3+ purity and post-separation viability.
Compatible with Existing Systems
Compatible with existing laboratory infrastructure.
Modular Technology
Adaptable antibody platform for future cell separation applications.
PERFORMANCE
High purity. High viability. Preserved functionality.
Cell Composition
Neptune™ T-Cell Separation System selectively removes unwanted cell populations while enriching CD3+ T cells from the initial PBMC population.
CD3 Yield
Neptune™ T-Cell Separation System achievies an average CD3+ yield of 63 %.
Post-Separation Viability
Cells retained greater than 85 % viability following separation.
SEE EXPERIMENTAL RESULTS
Click the button below to view experimental data demonstrating T-cell activation and expansion following separation with the Neptune™ T-Cell Separation System.
WANT TO LEARN MORE?